Latest Parkinson's disease Stories
REHOVOT, Israel, August 4, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd.
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition
VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
An experimental anti-inflammatory drug can protect vulnerable neurons and reduce motor deficits in a rat model of Parkinson’s disease.
ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million.
More Than 30 Scientific Projects Chosen for Potential to Improve the Lives and Futures of People Touched by Parkinson's NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- The Parkinson's
VIENNA, July 24, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
100% of donations raised will go to research KINGSTON, N.J., July 22, 2014 /PRNewswire-USNewswire/ -- Over 11,000 people from across the country came together on Saturday, April 26(th)
Initiative to optimize patient care spearheaded by AbbVie and The Michael J.
- The parings of haberdine; also, any kind of fragments.
More Images (1 images) »